PDCD1 and melanoma: We have also shown that high oxidative metabolism in patient derived melanoma tumor cells is associated with decreased function and increased exhaustion of TIL, with significantly worse clinical outcomes, suggesting that high oxidative metabolism in melanoma tumor cells is associated with resistance to anti-PD1 (27).